Straumann Holding AG (0QMV)
London Exchange · UK · prices in GBP · close of 15 Oct 2026
Key indicators
| Last close | GBP 94.20 |
|---|---|
| 52-week range | 73.24 – 122.34 |
| Return, 1 month / 3 months | −1.8% / −9.4% |
| Return, 1 year / 3 years | +7.7% / −18.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 52 |
| Volatility (1 year) | 44.7% |
| Worst drawdown (1 year) | -37.7% |
| Average daily value traded | 12.32M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Straumann Holding is a Swiss dental company based in Basel that supplies dental professionals with implants, prosthetic components and clear aligners for straightening teeth. It also provides digital dentistry equipment, materials and services used in restorative and orthodontic treatment. Its customers are dentists, oral surgeons, orthodontists and dental laboratories, served through subsidiaries and partners in many countries. The company focuses on tooth replacement and orthodontic solutions for everyday clinical practice.
On this site Straumann Holding AG appears as a stock on the London Exchange (UK), code 0QMV, with prices in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Straumann Holding AG (0QMV) trades on the London Exchange in UK. It last closed at GBP 94.20 on 15 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a weak price profile), ranking 2,088 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.7% and over the last three months it fell 9.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 49 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 0.3% | ||
| From 52-week high | -23.0% | ||
| Momentum | 50 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -9.4% | ||
| 6-month return | 6.5% | ||
| 12-month return, skipping the last month | 9.7% | ||
| Stability (higher is calmer) | 34 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.7% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 12.32M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +5.7% |
|---|---|
| 1 month | −1.8% |
| 3 months | −9.4% |
| 6 months | +6.5% |
| 1 year | +7.7% |
| 3 years | −18.9% |
| 5 years | −47.7% |
Signals
| 50-day / 200-day average | 95.40 / 93.96 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.29 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Apr 2026 | GBX 0.0100 |
| 14 Apr 2025 | GBX 0.0057 |
| 16 Apr 2024 | GBX 0.0045 |
| 11 Apr 2023 | GBX 0.0080 |
| 7 Apr 2022 | GBX 0.0675 |
| 13 Apr 2021 | GBX 0.0575 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.